<?xml version="1.0" encoding="UTF-8"?>
<p id="p0525">The US Governmentâ€™s Biomedical Advanced Research and Development Authority (BARDA) is funding the development and manufacturing of the ChAdOx1-S vaccine, the Phase 2 and 3 trials for the mRNA vaccine and the developed of recombinant vesicular stomatitis virus (rVSV), Adenovirus 26 (Ad26) and RNA vaccine candidates (in preclinical development). The US Department of Defense and other country governments are also funding vaccine development and manufacturing.</p>
